tiprankstipranks
Trending News
More News >
ReposiTrak (TRAK)
NYSE:TRAK

ReposiTrak (TRAK) AI Stock Analysis

Compare
129 Followers

Top Page

TR

ReposiTrak

(NYSE:TRAK)

Rating:72Outperform
Price Target:
$22.50
▲(14.16%Upside)
ReposiTrak shows strong financial performance and positive growth prospects, supported by a solid earnings call and strategic corporate events. However, technical indicators and valuation suggest caution due to potential overvaluation and short-term market pressures.
Positive Factors
Financial Position
The company has no debt and is paying a quarterly dividend, indicating a strong financial position.
Regulatory Compliance
ReposiTrak is well-positioned to capitalize on a ramp in food retailers' efforts to comply with the FDA traceability guidelines required by CY26.
Revenue Growth
High visibility for accelerating revenue in F2H25, with deferred revenue up 70.4% y/y, indicating traction with traceability initiatives.
Negative Factors
Financial Performance
Revenue, adjusted EBITDA, and GAAP EPS in F2Q25 came in light of projections.

ReposiTrak (TRAK) vs. SPDR S&P 500 ETF (SPY)

ReposiTrak Business Overview & Revenue Model

Company DescriptionReposiTrak, Inc. (TRAK) is a technology company operating within the supply chain and food safety sectors. It offers a comprehensive platform that provides compliance management, sourcing, food safety, and supply chain solutions. The company’s services cater to retailers, wholesalers, and suppliers, helping them streamline operations, ensure regulatory compliance, and enhance supply chain efficiency.
How the Company Makes MoneyReposiTrak generates revenue primarily through subscription fees for its platform services. The company offers various modules that clients can subscribe to, such as compliance management, sourcing, and food safety, which are essential for efficient supply chain operations. Key revenue streams include recurring subscription fees from retailers, wholesalers, and suppliers who rely on ReposiTrak's platform to manage and improve their supply chain processes. Additionally, the company may engage in strategic partnerships and collaborations to enhance its service offerings and expand its client base, further contributing to its earnings. Significant factors such as regulatory changes in food safety and supply chain management can also influence the demand for ReposiTrak's solutions, impacting revenue.

ReposiTrak Earnings Call Summary

Earnings Call Date:May 15, 2025
(Q3-2025)
|
% Change Since: -13.89%|
Next Earnings Date:Sep 24, 2025
Earnings Call Sentiment Positive
The earnings call highlighted significant revenue and net income growth, successful cross-selling, and a strong cash position. However, increased operating expenses and the FDA's extension of the compliance enforcement deadline were noted as challenges. Despite these challenges, the company remains optimistic about its growth prospects.
Q3-2025 Updates
Positive Updates
Revenue Growth
Revenue grew 16% in the third fiscal quarter to $5.9 million. Recurring revenue increased 15% to $5.8 million.
Net Income Growth
Net income grew 27% from $1.6 million to $2 million. GAAP net income to shareholders increased 33% from $1.4 million to $1.9 million.
Deferred Revenue Increase
Deferred revenue increased 70% to $4.2 million, indicating future revenue potential.
Cross-Selling Success
Cross-selling initiatives are gaining momentum, contributing to overall growth across all business lines.
Cash Position
Cash balance is over $28 million as of March 31, 2025, with significant cash generation and plans to return capital to shareholders.
Negative Updates
Operating Expense Increase
Operating expense increased 7% due to ongoing investments, which include marketing, technology, and onboarding costs.
FDA Compliance Deadline Extension
The FDA extended the compliance enforcement deadline by 30 months, which could potentially delay the expected rapid adoption of traceability solutions.
Increased Costs in G&A and Depreciation
G&A increased 8% and depreciation increased 14% due to leased equipment for a new data center.
Company Guidance
During ReposiTrak's fiscal third quarter 2025 earnings call, John Merrill, the CFO, provided guidance on the company's financial performance and strategic direction. The company reported a 16% growth in revenue to $5.9 million, with a significant increase in deferred revenue, indicating future growth. Net income grew by 27%, and the company aims to achieve 10-20% annual revenue growth. Their strategy focuses on expanding traceability and cross-selling their services, leading to increased profitability. Operating expenses increased by 7%, but the company maintains a strong cash position with $28.1 million on hand. ReposiTrak plans to continue returning 50% of its cash from operations to shareholders through dividends and stock buybacks, having already returned $25 million in capital. The company remains debt-free and is investing in growth through automation and customer onboarding.

ReposiTrak Financial Statement Overview

Summary
ReposiTrak displays a solid financial performance with robust revenue growth, profitability, and efficient capital management. The balance sheet shows financial stability with minimal reliance on debt, and cash flow statements indicate healthy liquidity and cash generation.
Income Statement
85
Very Positive
ReposiTrak has demonstrated strong revenue growth with a consistent increase from previous periods, showcasing a positive trajectory in the software industry. The company maintains robust profitability with solid gross and net profit margins, indicating efficient cost management and strong market demand. EBIT and EBITDA margins further reflect operational efficiency. The overall income statement presents a stable and growing financial performance.
Balance Sheet
88
Very Positive
The balance sheet of ReposiTrak is strong, with a high equity ratio reflecting a stable financial structure. The debt-to-equity ratio is low, indicating minimal reliance on debt for financing. Additionally, the high return on equity demonstrates the company's effective use of equity capital to generate profits. Overall, the balance sheet showcases financial stability and efficient capital management.
Cash Flow
82
Very Positive
ReposiTrak's cash flow statement is positive, with strong operating cash flow and free cash flow indicating healthy liquidity. The free cash flow to net income ratio is favorable, suggesting efficient conversion of income into cash. The positive growth rate in free cash flow reflects the company's ability to generate cash from operations, supporting future growth and investment opportunities.
BreakdownTTMJun 2024Jun 2023Jun 2022Jun 2021Jun 2020
Income Statement
Total Revenue22.03M20.45M19.10M18.05M21.01M20.04M
Gross Profit18.41M17.04M14.71M13.98M13.10M12.20M
EBITDA8.62M7.61M7.11M5.38M5.41M2.62M
Net Income6.76M5.96M5.59M4.00M4.12M1.59M
Balance Sheet
Total Assets54.83M51.60M50.58M49.32M55.05M53.43M
Cash, Cash Equivalents and Short-Term Investments28.13M25.15M23.99M21.46M24.07M20.35M
Total Debt777.63K481.02K747.11K2.97M6.70M7.47M
Total Liabilities5.91M4.74M4.70M6.42M9.91M10.85M
Stockholders Equity48.92M46.85M45.88M42.90M45.14M42.58M
Cash Flow
Free Cash Flow8.75M6.89M7.96M6.05M5.08M3.55M
Operating Cash Flow8.82M6.96M8.86M6.10M5.40M4.20M
Investing Cash Flow-45.85K-100.71K-903.19K1.32M-318.87K-650.42K
Financing Cash Flow-5.09M-5.70M-5.43M-10.03M-1.36M-1.81M

ReposiTrak Technical Analysis

Technical Analysis Sentiment
Negative
Last Price19.71
Price Trends
50DMA
21.24
Negative
100DMA
20.59
Negative
200DMA
20.79
Negative
Market Momentum
MACD
-0.48
Negative
RSI
41.92
Neutral
STOCH
57.05
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TRAK, the sentiment is Negative. The current price of 19.71 is below the 20-day moving average (MA) of 20.11, below the 50-day MA of 21.24, and below the 200-day MA of 20.79, indicating a bearish trend. The MACD of -0.48 indicates Negative momentum. The RSI at 41.92 is Neutral, neither overbought nor oversold. The STOCH value of 57.05 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TRAK.

ReposiTrak Risk Analysis

ReposiTrak disclosed 26 risk factors in its most recent earnings report. ReposiTrak reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

ReposiTrak Peers Comparison

Overall Rating
UnderperformOutperform
Sector (50)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
78
Outperform
$469.31M35.936.11%7.76%
75
Outperform
$609.10M160.141.94%3.62%-53.21%
72
Outperform
$358.95M59.1614.17%0.37%9.73%22.33%
59
Neutral
$601.11M48.46%-0.81%9.83%
59
Neutral
$414.11M-64.59%5.33%58.41%
58
Neutral
$680.69M-46.57%-2.39%-2961.26%
50
Neutral
C$2.92B1.79-63.12%2.58%11.24%-12.42%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
TRAK
ReposiTrak
19.71
2.44
14.13%
MITK
Mitek Systems
9.89
-1.62
-14.07%
DOMO
Domo
14.98
7.13
90.83%
BIGC
BigCommerce Holdings
5.20
-2.54
-32.82%
PUBM
PubMatic
13.58
-6.62
-32.77%
BMBL
Bumble
6.71
-2.68
-28.54%

ReposiTrak Corporate Events

Dividends
ReposiTrak Announces Quarterly Dividend Increase
Positive
Jun 23, 2025

On June 20, 2025, ReposiTrak, Inc. announced a quarterly cash dividend of $0.01815 per share, payable on August 14, 2025, to shareholders of record on June 30, 2025. The company also revealed a 10% increase in its quarterly dividend, raising it to $0.02 per share starting with the dividend payable on November 14, 2025, marking the third increase since the dividend’s inception. This move underscores ReposiTrak’s commitment to providing value to its shareholders and may enhance its attractiveness to investors.

The most recent analyst rating on (TRAK) stock is a Buy with a $24.00 price target. To see the full list of analyst forecasts on ReposiTrak stock, see the TRAK Stock Forecast page.

DividendsBusiness Operations and StrategyFinancial Disclosures
ReposiTrak Reports 16% Revenue Increase in Q3 2025
Positive
May 19, 2025

ReposiTrak reported a 16% increase in total revenue, reaching $5.9 million for the third fiscal quarter ended March 31, 2025, with a 27% rise in net income. The company attributes this growth to successful cross-selling across its business lines, particularly in traceability, compliance, and supply chain solutions. The onboarding of traceability customers has shifted from retailers to suppliers, expanding the company’s market potential. The company also redeemed preferred shares and declared a quarterly dividend, maintaining a strong cash position with no bank debt.

The most recent analyst rating on (TRAK) stock is a Buy with a $24.00 price target. To see the full list of analyst forecasts on ReposiTrak stock, see the TRAK Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jun 24, 2025